.
Censo is headquartered in Roslin, United Kingdom.
Censo is a life science company.
Censo was founded in 2016.
Join Mergr to view all 0 acquisitions of life science companies in , including .
Charnock Bradley Building, Easter Bush,
Roslin,
EH25 9RG
United Kingdom,
0131 651 9710
www.censobio.com
Censo is a cell biology CRO with focused expertise in iPSC-related technologies. The company creates relevant, customizable human neurological and inflammatory disease models with induced pluripotent stem cells (iPSC). With deep expertise in neuroscience, immunology, stem cell biology, and gene editing, Censo Biotechnologies specializes in model and assay design for drug discovery. Censo has the ability to select or engineer the desired human genetic background by creating iPSC from patient samples or using CRISPR for gene editing. It has established robust, propriety differentiation protocols for sensory and excitatory cortical neurons, astrocytes, microglia, macrophages, monocytes, and dendritic cells as well as co-cultures. Censo was formed in 2016 and is based in Roslin, United Kingdom.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
